Form 8-K - Current report:
SEC Accession No. 0001069530-20-000071
Filing Date
2020-12-11
Accepted
2020-12-11 16:43:25
Documents
2
Period of Report
2020-12-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sava-20201211x8k.htm 8-K 40925
2 EX-3.1 sava-20201211xex3_1.htm EX-3.1 279721
  Complete submission text file 0001069530-20-000071.txt   321923
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 201383977
SIC: 2834 Pharmaceutical Preparations